Cardiovascular Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Miravant Medical Technologies
Photoselective medicine company announces financial results
April 26th, 2005
Miravant Medical Technologies (MRVT) announced consolidated financial results for the fourth quarter and the year ended December 31, 2004. The net loss for the quarter was $3.3 million or ($0.09) per share, compared to a net loss of $1.6 million or ($0.06) per share for the same period in 2003. The company reported a net loss for the year ended December 31, 2004, of $15.9 million or ($0.48) per share, compared to a net loss of $7.5 million or ($0.30) per share for the year ended 2003. The comparative differences were largely the result of a gain on the retirement of company debt and the selling of certain investment assets in 2003. The company had...
Source: Cardiovascular Business Week (2005-04-26)
|
